ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 9 of 32
УЖМБС 2022, 7(6): 62–69
Clinical Medicine

Peculiarities of Somatic and Gynecological Status of Women with Abnormal Uterine Bleeding with Autoimmune Thyroiditis

Alekseeva O. S., Lazurenko V. V.

The purpose of the study was to determine the peculiarities of somatic and gynecological status of women with abnormal uterine bleeding, who have autoimmune thyroiditis. Materials and methods. 120 women of reproductive age, of whom there were 90 patients with abnormal uterine bleeding and 30 women without gynecological pathology (control group), were examined. Patients from the main group were divided into 2 clinical groups: 60 women with autoimmune thyroiditis were included in the main group and 30 women without signs of thyroid gland pathology made up the comparison group. The research was conducted and the results of anamnestic data, somatic and gynecological status, clinical laboratory and ultrasound examinations, conservative and operative treatment were analyzed. The study was conducted in the gynecological department of the Communal Non-Commercial Enterprise of the Kharkiv Regional Council “Kharkiv Regional Clinical Hospital” during 2019-2022. Statistical processing of the obtained data was performed using the “Statistica 6.0” program. Results and discussion. As a result of the analysis of the anamnesis data of the patients of the main group, a hereditary predisposition to thyroid gland diseases was revealed in the closest relatives of every fifth patient with autoimmune thyroiditis. Among the concomitant gynecological pathology, such diseases as uterine leiomyoma, endometriosis of various localization, endometrial hyperplasia were more common in patients with uterine bleeding in combination with autoimmune thyroiditis (38.3%). In addition, fibrocystic mastopathy was also observed almost twice as often in patients with abnormal uterine bleeding against the background of autoimmune thyroiditis (25%) than in the group without thyroid gland pathology, which may be due to the hormonal dependence of the above-mentioned diseases, and is a predictor of the development of hereditary endocrine dysfunction and greater susceptibility of the reproductive system to exogenous and endogenous factors. When studying the somatic status of patients with abnormal uterine bleeding in combination with autoimmune thyroiditis, a significant prevalence of comorbid somatic pathology was noted. Among women with 2-3 concomitant diseases, the following combinations were most common: hypertension and obesity (13%); hypertension, chronic pancreatitis, varicose veins of the lower extremities (7%), chronic pyelonephritis, fibrocystic mastopathy. Every third patient had a combination of obesity, liver disease, and hypertension. It should be noted that in women with abnormal uterine bleeding without autoimmune thyroiditis, the accompanying pathology was twice as low as in the group suffering from the specified thyroid disease. Menstrual cycle disorders of various nature were detected. Irregular menstrual cycle occurred twice as often in women with abnormal uterine bleeding against the background of autoimmune thyroiditis than in women without concomitant thyroid disease – in 8 (13.3%) and 2 (6.7%) women, respectively. The analysis of the peculiarities of the generative function allowed to reveal a statistically significant predominance of women with primary infertility (13.3%). Secondary infertility occurred almost twice as often and was diagnosed in 20% of women. Almost every third woman with abnormal uterine bleeding and autoimmune thyroiditis had a history of reproductive loss (35%). In 16.7% of patients, habitual miscarriage was revealed. 3.33% had a history of ectopic pregnancy. Conclusion. The analysis of somatic diseases in women with autoimmune thyroiditis demonstrates their influence on the development of gynecological pathology, especially menstrual cycle disorders, in particular abnormal uterine bleeding, which requires the search for new approaches to their treatment and prevention

Keywords: abnormal uterine bleeding, autoimmune thyroiditis, somatic pathology

Full text: PDF (Ukr) 263K

  1. Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018;14(5):301-16. PMID: 29569622. doi: 10.1038/nrendo.2018.18
  2. Joshi BR, Rizal S, Subedi S. Thyroid Dysfunction in Patient with Abnormal Uterine Bleeding in a Tertiary Hospital of Eastern Nepal: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2021;59(239):635-9. PMID: 34508505. PMCID: PMC9107865. doi: 10.31729/jnma.6487
  3. Andriiets' OA, Yuz'ko OM, Tsysar YuV. Asotsiatsiia hennoho polimorfizmu z menorahiiamy, poiednanymy z tyreoidnoiu patolohiieiu [Association of gene polymorphism with menorrhagia associated with thyroid pathology]. Reprod Endokrynol. 2020;6:73-4. [Ukrainian]. doi: 10.18370/2309-4117.2020.56.73-77
  4. Benetti-Pinto CL, Japur de Sá Rosa-E-Silva AC, Yela DA, Soares Júnior JM. Abnormal Uterine Bleeding. Rev Bras Ginecol Obstet. 2017;39(7):358-68. PMID: 28605821. doi: 10.1055/s-0037-1603807
  5. Marnach ML, Laughlin-Tommaso SK. Evaluation and Management of Abnormal Uterine Bleeding. Mayo Clin Proc. 2019;94(2):326-35. PMID: 30711128. doi: 10.1016/j.mayocp.2018.12.012
  6. Verma K, Verma S, Rajoria L. A cross sectional study to evaluate the relation between thyroid disorders and abnormal uterine bleeding in reproductive age group. Indian J Obstetr Gynecol Res. 2019;6(2):177-180. doi: 10.18231/j.ijogr.2019.041
  7. Thakur M, Maharjan M, Tuladhar H, Dwa Y, Bhandari S, Maskey S, et al. Thyroid Dysfunction in Patients with Abnormal Uterine Bleeding in a Tertiary Care Hospital: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc. 2020;58(225):333-7. PMID: 32538929. PMCID: PMC7654461. doi: 10.31729/jnma.5033
  8. Munro M G. Practical aspects of the two FIGO systems for management of abnormal uterine bleeding in the reproductive years. Best Pract Res Clin Obstet Gynaecol. 2017;40:3-22. PMID: 27836285. doi: 10.1016/j.bpobgyn.2016.09.011
  9. Khafaga A, Goldstein SR. Abnormal Uterine Bleeding. Obstet Gynecol Clin North Am. 2019;46(4): 595-605. PMID: 31677744. doi: 10.1016/j.ogc.2019.07.001
  10. Annaldasula A, Gouroju S. Consideration of thyroid dysfunction for menstrual abnormalities in premenopausal women. Int J Integrat Med Scien. 2018;5(6):650-4. doi: 10.16965/ijims.2018.116
  11. Mendes D, Alves C, Silverio N, Marques F. B. Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis. Eur Thyroid J. 2019;8(3):130-143. PMID: 31259155. PMCID: PMC6587201. doi: 10.1159/000499751
  12. Yuzko OM. Porushennya funktsiya shchytopodibnoyi zalozy v zhinok iz bezpliddyam ta anomalnymy matkovymy krovotechamy [Dysfunction of the thyroid gland in women with infertility and abnormal uterine bleeding]. Klin Eksp Med. 2018;17(3):109-12. [Ukrainian]. doi: 10.24061/1727-4338.XVII.3.65.2018.142
  13. Deshmukh PY, Boricha BG, Pandey A. The association of thyroid disorders with abnormal uterine bleeding. Int J Reprod Contracept Obstet Gynecol. 2015;4(3):701-8. doi: 10.18203/2320-1770.ijrcog20150077
  14. Barya S, Goyal S, Maheshwari S. Evaluation of Thyroid Dysfunction in Abnormal Uterine Bleeding. Int J Health Clin Res. 2021;4(2):142-4. PMID: 32028485. doi: 10.1097/AOG.0000000000003693
  15. Tehseen M, Naushaba R, Syed FU, Shahla AM. Abnormal uterine Bleeding in Patient Having Thyroid Dysfunction. Int J Multidiscipl Curr Res. 2020;8:196-200. doi: 10.14741/ijmcr/v.8.2.7